Zentrela Inc. is a Canadian neurotechnology pioneer and creator of the first true scientific method for measuring the actual psychoactive effects of cannabis. Zentrela is advancing the world’s understanding of cannabis by creating the largest scientific database of consumer cannabis experiences through Observational Studies.
Our vision is to set the standard for measuring cannabis effects by becoming the most reliable and accurate provider of cannabis effect information.
Our consumer research is powered by the Cognalyzer, our proprietary neurotechnology platform that uses advanced machine learning algorithms to analyze consumer EEG data.
Founders
Israel Gasperin
Founder
Featured Stories
Study confirms accuracy of Zentrela’s neurotechnology
On April 6, an independent blind study was released confirming that Zentrela’s cutting-edge “Cognalyzer®” neurotechnology accurately detects and quantifies actual...
Zentrela receives $850K to build scientific database of cannabis product effects
On February 11, 2021, The Forge alumnus, Zentrela Inc. announced that it has completed an $850K seed funding round led...